Anquillare Mark V's Form 4 filing
Verisk Analytics, Inc. (VRSK) · filed Dec 20, 2021
- Accession no.
- 0001209191-21-070605
- Filed
- Dec 20, 2021
- Trade date
- Dec 20, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.47M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anquillare Mark VCIK 0001472710 | Officer (Group President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | Common Stock | MOption exerciseAcquired | +20,480 | $61.14 | +$1,252,147.2 | 41,982 | Direct | |
| Dec 20, 2021 | Common Stock | SSaleDisposed | −300 | $214.71F1 | −$64,413 | 41,682 | Direct | |
| Dec 20, 2021 | Common Stock | SSaleDisposed | −400 | $216.02F2 | −$86,408 | 41,282 | Direct | |
| Dec 20, 2021 | Common Stock | SSaleDisposed | −4,600 | $216.82F3 | −$997,372 | 36,682 | Direct | |
| Dec 20, 2021 | Common Stock | SSaleDisposed | −7,968 | $217.98F4 | −$1,736,864.64 | 28,714 | Direct | |
| Dec 20, 2021 | Common Stock | SSaleDisposed | −7,212 | $219.18F5 | −$1,580,726.16 | 21,502 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | Common Stock | MOption exerciseDisposed | −20,480 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $214.56 to $215.00, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1).
Referenced by the price of 1 transaction in Table I.
- F2
These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $215.80 to $216.43, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2).
Referenced by the price of 1 transaction in Table I.
- F3
These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $216.77 to $217.54, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (3).
Referenced by the price of 1 transaction in Table I.
- F4
These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $217.56 to $218.46, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (4).
Referenced by the price of 1 transaction in Table I.
- F5
These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $218.57 to $219.55, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (5).
Referenced by the price of 1 transaction in Table I.